Literature DB >> 20469990

PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.

Benjamin D Kläsner1, Bernd J Krause, Ambros J Beer, Alexander Drzezga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20469990     DOI： 10.1586/era.10.37

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  11 in total

1.  Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.

Authors:  Ken Herrmann; Johannes Czernin; Timothy Cloughesy; Albert Lai; Kelsey L Pomykala; Matthias R Benz; Andreas K Buck; Michael E Phelps; Wei Chen
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

2.  Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.

Authors:  Sriram Venneti; Mark P Dunphy; Hanwen Zhang; Kenneth L Pitter; Patrick Zanzonico; Carl Campos; Sean D Carlin; Gaspare La Rocca; Serge Lyashchenko; Karl Ploessl; Daniel Rohle; Antonio M Omuro; Justin R Cross; Cameron W Brennan; Wolfgang A Weber; Eric C Holland; Ingo K Mellinghoff; Hank F Kung; Jason S Lewis; Craig B Thompson
Journal:  Sci Transl Med       Date:  2015-02-11       Impact factor: 17.956

Review 3.  Glioblastoma and Methionine Addiction.

Authors:  Mark L Sowers; Lawrence C Sowers
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

4.  Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.

Authors:  Limin Wang; Brian P Lieberman; Karl Ploessl; Hank F Kung
Journal:  Nucl Med Biol       Date:  2013-10-09       Impact factor: 2.408

5.  Radiosynthesis of Carbon-11 Labeled Puromycin as a Potential PET Candidate for Imaging Protein Synthesis in Vivo.

Authors:  Selena Milicevic Sephton; Franklin I Aigbirhio
Journal:  ACS Med Chem Lett       Date:  2016-04-12       Impact factor: 4.345

6.  The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.

Authors:  Alexandra Winkeler; Raphael Boisgard; Ali R Awde; Albertine Dubois; Benoit Thézé; Jinzi Zheng; Luisa Ciobanu; Frédéric Dollé; Thomas Viel; Andreas H Jacobs; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-21       Impact factor: 9.236

7.  Reply to Flugge: the anti-metastatic potential of methionine restriction in melanoma.

Authors:  Isabelle R Miousse; Julia Tobacyk; Charles M Quick; Azemat Jamshidi-Parsian; Charles M Skinner; Rajshekhar Kore; Stepan B Melnyk; Kristy R Kutanzi; Fen Xia; Robert J Griffin; Igor Koturbash
Journal:  Carcinogenesis       Date:  2020-05-14       Impact factor: 4.741

Review 8.  PET/MR: a paradigm shift.

Authors:  Florian C Gaertner; Sebastian Fürst; Markus Schwaiger
Journal:  Cancer Imaging       Date:  2013-02-27       Impact factor: 3.909

9.  Development of a high affinity Anticalin® directed against human CD98hc for theranostic applications.

Authors:  Friedrich-Christian Deuschle; Volker Morath; André Schiefner; Corinna Brandt; Simone Ballke; Sybille Reder; Katja Steiger; Markus Schwaiger; Wolfgang Weber; Arne Skerra
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

Review 10.  Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas.

Authors:  Filipa Martins; Luís G Gonçalves; Marta Pojo; Jacinta Serpa
Journal:  Biomolecules       Date:  2020-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.